000 01530 a2200409 4500
005 20250513110719.0
264 0 _c19970401
008 199704s 0 0 eng d
022 _a1073-2322
024 7 _a10.1097/00024382-199701000-00004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMclntyre, R C
245 0 0 _aSelective inhibition of receptor-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury.
_h[electronic resource]
260 _bShock (Augusta, Ga.)
_cJan 1997
300 _a36-41 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdenosine Diphosphate
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aDimaprit
_xpharmacology
650 0 4 _aEndotoxins
_xpharmacology
650 0 4 _aLung Diseases
_xchemically induced
650 0 4 _aMale
650 0 4 _aPhenylephrine
_xpharmacology
650 0 4 _aPulmonary Circulation
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aReceptors, Adrenergic, beta
_xmetabolism
650 0 4 _aReceptors, Cell Surface
_xdrug effects
650 0 4 _aReceptors, Histamine H2
_xmetabolism
650 0 4 _aReceptors, Purinergic P2
_xmetabolism
650 0 4 _aVasodilation
_xdrug effects
700 1 _aSheridan, B
700 1 _aAgrafojo, J
700 1 _aFullerton, D A
773 0 _tShock (Augusta, Ga.)
_gvol. 7
_gno. 1
_gp. 36-41
856 4 0 _uhttps://doi.org/10.1097/00024382-199701000-00004
_zAvailable from publisher's website
999 _c8981247
_d8981247